Display options
Share it on

Environ Health Insights. 2016 Mar 28;10:51-7. doi: 10.4137/EHI.S31906. eCollection 2016.

Carbon Disulfide (CS2) Interference in Glucose Metabolism from Unconventional Oil and Gas Extraction and Processing Emissions.

Environmental health insights

Alisa L Rich, Jay T Patel, Samiah S Al-Angari

Affiliations

  1. Department of Environmental and Occupational Health Sciences, University of North Texas Health Science Center, Fort Worth, TX, USA.; WHO Chemical Risk Assessment Network.
  2. Department of Environmental and Occupational Health Sciences, University of North Texas Health Science Center, Fort Worth, TX, USA.

PMID: 27042092 PMCID: PMC4811267 DOI: 10.4137/EHI.S31906

Abstract

Carbon disulfide (CS2) has been historically associated with the manufacturing of rayon, cellophane, and carbon tetrachloride production. This study is one of the first to identify elevated atmospheric levels of CS2 above national background levels and its mechanisms to dysregulate normal glucose metabolism. Interference in glucose metabolism can indirectly cause other complications (diabetes, neurodegenerative disease, and retinopathy), which may be preventable if proper precautions are taken. Rich et al found CS2 and 12 associated sulfide compounds present in the atmosphere in residential areas where unconventional shale oil and gas extraction and processing operations were occurring. Ambient atmospheric concentrations of CS2 ranged from 0.7 parts per billion by volume (ppbv) to 103 ppbv over a continuous 24-hour monitoring period. One-hour ambient atmospheric concentrations ranged from 3.4 ppbv to 504.6 ppbv. Using the U.S. Environmental Protection Agency Urban Air Toxic Monitoring Program study as a baseline comparison for atmospheric CS2 concentrations found in this study, it was determined that CS2 atmospheric levels were consistently elevated in areas where unconventional oil and gas extraction and processing occurred. The mechanisms by which CS2 interferes in normal glucose metabolism by dysregulation of the tryptophan metabolism pathway are presented in this study. The literature review found an increased potential for alteration of normal glucose metabolism in viscose rayon occupational workers exposed to CS2. Occupational workers in the energy extraction industry exposed to CS2 and other sulfide compounds may have an increased potential for glucose metabolism interference, which has been an indicator for diabetogenic effect and other related health impacts. The recommendation of this study is for implementation of regular monitoring of blood glucose levels in CS2-exposed populations as a preventative health measure.

Keywords: carbon disulfide; diabetes; glucose metabolism; natural gas; tryptophan pathway; unconventional shale

References

  1. Br J Nutr. 1990 Jan;63(1):27-36 - PubMed
  2. Am Fam Physician. 1991 Nov;44(5):1651-8 - PubMed
  3. Ann Med. 2000 Apr;32(3):210-21 - PubMed
  4. Lancet. 1991 May 11;337(8750):1121-4 - PubMed
  5. Am Heart J. 1972 Jan;83(1):100-14 - PubMed
  6. Nat Med. 2003 Oct;9(10):1269-74 - PubMed
  7. Crit Rev Toxicol. 2009 Oct;39 Suppl 2:1-126 - PubMed
  8. Int Arch Arbeitsmed. 1971;28(2):115-26 - PubMed
  9. Transplant Proc. 1998 Sep;30(6):2682-4 - PubMed
  10. Future Med Chem. 2015;7(2):185-201 - PubMed
  11. Mol Neurobiol. 2013 Oct;48(2):294-301 - PubMed
  12. Adv Exp Med Biol. 2003;527:481-96 - PubMed
  13. J Nutr. 2013 Sep;143(9):1509-19 - PubMed
  14. Diabetes Care. 2013 Apr;36(4):1033-46 - PubMed
  15. Environ Res. 1982 Oct;29(1):151-9 - PubMed
  16. Acta Diabetol Lat. 1979 Jul-Sep;16(3):259-63 - PubMed
  17. Trends Mol Med. 2004 Jan;10(1):15-8 - PubMed
  18. Br J Ind Med. 1993 Apr;50(4):301-7 - PubMed
  19. Clin Chem. 1998 Apr;44(4):858-62 - PubMed
  20. Int J Occup Environ Health. 2001 Jan-Mar;7(1):7-13 - PubMed
  21. Med Hypotheses. 1985 Dec;18(4):371-6 - PubMed
  22. Sleep Med Rev. 2002 Feb;6(1):55-69 - PubMed
  23. Biochem Pharmacol. 1971 Aug;20(8):2114-5 - PubMed
  24. J Air Waste Manag Assoc. 2014 Jan;64(1):61-72 - PubMed
  25. Br Med J. 1975 Jul 5;3(5974):13-5 - PubMed
  26. Lung Cancer. 2010 Mar;67(3):361-5 - PubMed
  27. Eur J Clin Invest. 2003 Jul;33(7):550-4 - PubMed
  28. Clin Rheumatol. 2006 May;25(3):334-7 - PubMed
  29. J Biochem. 1975 Mar;77(3):685-7 - PubMed
  30. JAMA. 2003 Oct 8;290(14):1884-90 - PubMed
  31. J Exp Med. 2002 Aug 19;196(4):447-57 - PubMed
  32. Neurogastroenterol Motil. 2009 Dec;21(12):1239-49 - PubMed
  33. Eur J Pharmacol. 1999 Jun 30;375(1-3):87-100 - PubMed
  34. Int Arch Occup Environ Health. 1976 Apr 28;37(1):1-8 - PubMed
  35. Trends Mol Med. 2013 Jun;19(6):336-44 - PubMed

Publication Types